Epicillin exhibits excellent therapeutic activity when administered orally or subcutaneously to mice infected with a variety of pathogenic bacteria. These included single strains of Streptococcus pyogenes, non-penicillinase-producing Staphylococcus aureus, Proteus mirabilis, Escherichia coli, Salmonella schottmuelleri, and Pseudomonas aeruginosa, strains of microorganisms selected as typical of those that frequently cause serious clinical infections. In oral chemotherapeutic comparisons of tetracycline, chloramphenicol, cephalexin, ampicillin, and epicillin, the latter, with but minor exceptions, exhibited activity comparable to that of most of the other antibiotics studied. Oral administration to mice of a loading dose of epicillin or ampicillin resulted in similar peak blood levels and decay curves. The concentration in urine and the excretion rates were significantly higher in epicillin than in ampicillin-treated animals. Presumptive evidence suggests that the interpretation of zone diameters obtained with 10-,ug epicillin discs should be the same as is used for 10-,ug ampicillin discs.
As part of broad studies in the area of new semisynthetic anti-infective agents, we became interested in structures derived from 1,4-cyclohexadienyl-substituted-a-amino acids. Whereas the 1 ,4-cyclohexadienyl ring, much like the benzene ring, was expected to be planar, differences in affinities for active sites on various enzymes might be anticipated. Thus, in addition to modified potency, alteration in patterns of absorption, tissue penetration, and distribution as well as metabolism and excretion could distinguish the aromatic from the dihydro forms. In the penicillin family, the physical, chemical, and biological properties in vitro of epicillin have been described (1) . The present report will deal with (i) an evaluation of this drug in experimental bacterial infections in mice and a comparison of its activity with that of other antibacterial agents, (ii) its blood levels achieved and its urinary excretion in mice, as well as (iii) preliminary correlation of susceptibility data with clinical response. Blood and urine samples. Groups of five mice were given a single 400 mg/kg dose of the sodium salt of epicillin or ampicillin by gavage, with water or 5% gum acacia as a vehicle. The groups of animals were housed in metabolism cages to permit the collection of the total urine output during the 6-hr period after drug administration. At specified intervals, groups of mice were bled from the orbital sinus; the serum was then separated by centrifugation and stored at 4 C. Both sera and urines were assayed on the day of collection by a disc-diffusion assay with Staphylococcus aureus P-209 as the test organism (1).
Disc susceptibiilty testing. All strains of bacteria were tested for susceptibility to epicillin by the discdiffusion procedure, essentially as described by Bauer et al. (2) . Mueller-Hinton agar, with and without 2% rabbit blood, poured to a depth of ca. 4 mm was used as the test medium. After incubation for 18 to 24 hr at 37 C, arithmetic means were computed from the measurements of three zones.
Minimal inhibitory concentration determinations. Twofold broth and agar dilution tests were used to determine the susceptibility to epicillin of clinical isolates as described in the previous paper (1 The oral chemotherapeutic activity of epicillin in mice was compared with that of other broad/ medium spectrum antibiotics (Table 2) . In most cases, epicillin showed a degree of activity in vivo against six representative bacteria which was greater than that exhibited by tetracycline, chloramphenicol, and cephalexin but similar to that of ampicillin.
Preclinical pharmacology. After the oral administration to mice of a single loading dose of 400 mg/kg of the sodium salt of either epicillin or ampicillin, peak blood levels of ca. 20 ,ug/ml were reached at approximately 30 min ( Fig. 1 ) and fell off rapidly during the ensuing 5.5 hr.
The. serum half-life of both antibiotics was approximately 60 min. Urine excreted by these animals during the 6-hr test period showed a mean concentration (based on total bioactivity) of epicillin (1,030 jig/ml) that was significantly higher (P < 0.001) than that obtained with ampi- .250
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. cillin (650 ,g/ml). The excretion rate of the two antibiotics during the same period, based on administered dose, was 37% for epicillin and 26% for ampicillin. This difference was statistically significant (P < 0.05). The reason(s) for these differences are being investigated.
Laboratory-clinical correlation studies. With the initiation of clinical efficacy studies, preliminary correlation between laboratory (MIC or zone size) and clinical (therapeutic response) data became possible. Participating investigators were asked to submit to the Squibb Institute slants of pretreatment cultures from patients about to enter the Preliminary Efficacy Study (U.S. Phase II). These cultures were identified with respect to genus and species and were tested by broth or agar dilution (MIC) and by Bauer-Kirby discdiffusion (zone size) techniques. The data were subsequently plotted (Fig. 2) and subjected to regression analysis. The correlation coefficient between log2 MIC and zone diameter was 0.91. The t test on the regression coefficient showed it to be significantly different from zero with P < 0.001.
In addition, cultures from patients that had demonstrated a good to excellent clinical response to epicillin were differentiated from those that came from subjects that had responded less satisfactorily (Fig. 2) . On the basis of these early clinical studies, it appeared that the well known interpretation of zone diameters obtained with 10-,ug ampicillin discs (gram-positive cocci, enterococci, and gram-negative organisms; reference 2) could also be applied tentatively to 10-,ug epicillin discs. Interpretive values for Haemophilus would be expected to be similar but must await the results of additional clinical trials.
